DR REDDYS LABORATORIES LTD UNIT II

DR REDDYS LABORATORIES LTD UNIT II is a factory.

DR REDDYS LABORATORIES LTD UNIT II Company Introduction:

DR REDDYS LABORATORIES LTD UNIT II is a manufacturing facility belonging to Dr. Reddy's Laboratories Ltd., a prominent Indian multinational pharmaceutical company. Dr. Reddy's is engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products globally, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) products.

Unit II specifically refers to one of its dedicated manufacturing plants. These units are crucial for the company's production capabilities, adhering to stringent international quality standards such as Good Manufacturing Practices (GMP). This facility is involved in the industrial-scale production of various pharmaceutical formulations or active ingredients, contributing to Dr. Reddy's extensive product portfolio and its commitment to providing affordable and innovative medicines worldwide. As a factory, its primary function is the large-scale production and processing of pharmaceutical goods.

DR REDDYS LABORATORIES LTD UNIT II, as part of Dr. Reddy's Laboratories, contributes to the production and sale of a diverse portfolio of pharmaceutical products globally. These products span various therapeutic areas and include branded generics, biosimilars, and active pharmaceutical ingredients.

The product range encompasses, but is not limited to, the following therapeutic categories and examples:

Gastroenterology:

Omez (Omeprazole)

Razo (Rabeprazole)

Pantoprazole formulations

Pain Management:

Nise (Nimesulide)

Sumatriptan formulations

Naproxen formulations

Cardiovascular:

Stamlo (Amlodipine)

Crestor (Rosuvastatin, generic)

Atorvastatin formulations

Metoprolol formulations

Oncology:

Reditux (Rituximab biosimilar)

Peg-grafeel (Pegfilgrastim biosimilar)

Generic chemotherapy drugs such as Bortezomib, Lenalidomide

Diabetes:

Generic formulations for blood glucose management, including Metformin and Glimepiride

Dermatology:

Various topical creams, ointments, and systemic treatments for skin conditions

Neurology:

Generic formulations for conditions such as migraine, epilepsy, and depression, including Sertraline and Gabapentin

Immunology:

Biosimilars and other immunomodulators for autoimmune diseases

Critical Care:

Products for intensive care units and hospital settings, including injectables and anti-infectives

Active Pharmaceutical Ingredients (APIs):

A wide array of APIs for various therapeutic uses, supplied to other pharmaceutical companies worldwide.

Additionally, Dr. Reddy's Laboratories offers a broad portfolio of generic drugs in markets such as North America and Europe, covering numerous therapeutic classes once patents expire, including psychiatric drugs, anti-infectives, and central nervous system agents.